Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

Epstein-Barr virus (EBV) is a human herpes virus that infects over 90% of the world’s population and is linked to development of cancer. In immune-competent individuals, EBV infection is mitigated by a highly efficient virus-specific memory T-cell response. Risk of EBV-driven cancers increases with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccines (Basel)
Main Authors: Ahmed, Elshafa Hassan, Brooks, Eric, Sloan, Shelby, Schlotter, Sarah, Jeney, Frankie, Hale, Claire, Mao, Charlene, Zhang, Xiaoli, McLaughlin, Eric, Shindiapina, Polina, Shire, Salma, Das, Manjusri, Prouty, Alexander, Lozanski, Gerard, Mamuye, Admasu T., Abebe, Tamrat, Alinari, Lapo, Caligiuri, Michael A., Baiocchi, Robert A.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8228306/
https://ncbi.nlm.nih.gov/pubmed/34073261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9060555
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados